@misc{10481/97957,
year = {2019},
month = {4},
url = {https://hdl.handle.net/10481/97957},
abstract = {There is a special interest in the implementation of pharmacogenetics in clinical practice,
although there are some barriers that are preventing this integration. A large part of these
pharmacogenetic tests are focused on drugs used in oncology and psychiatry fields and for antiviral
drugs. However, the scientific evidence is also high for other drugs used in other medical areas, for
example, in cardiology. In this article, we discuss the evidence and guidelines currently available on
pharmacogenetics for clopidogrel, warfarin, acenocoumarol, and simvastatin and its implementation
in daily clinical practice.},
publisher = {MDPI},
keywords = {pharmacogenetics},
keywords = {clopidogrel},
keywords = {warfarin},
title = {Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine},
doi = {10.3390/genes10040261},
author = {Dávila Fajardo, Cristina Lucía and Díaz Villamarín, Xando and Antúnez Rodríguez, Alba and Fernández Gómez, Ana Estefanía and García Navas, Paloma and Martínez González, Luis Javier and Dávila Fajardo, José Augusto and Cabeza-Barrera, José},
}